True Progress in Orthobiologics Requires That We Police Ourselves and Each Other

Scott P. Bruder, MD, PhD

The orthobiologic product segment now represents 10 percent of the worldwide orthopaedic marketplace, with 2019 sales exceeding $5 billion worldwide. Sadly, however, there are far too many cases where companies have improperly side-stepped the FDA, misguided clinicians, and defrauded not only the surgeon community but also the general public and other federal agencies as well. Fortunately, AAOS is now dedicating more resources and focus to the topic of biologic product development and responsible clinical use. Formation